Recently Viewed
Clear AllToday’s Range
52 Week Range
Liquidity
Market cap
$2,105 Mln
Revenue (TTM)
$3,313 Mln
Net Profit (TTM)
$0 Mln
ROE
-0.4 %
ROCE
-- %
P/E Ratio
--
P/B Ratio
1.1
Industry P/E
--
EV/EBITDA
9.6
Div. Yield
0 %
Debt to Equity
1.4
Book Value
$21.5
EPS
$-12.2
Face value
--
Shares outstanding
92,034,218
CFO
$3,739.92 Mln
EBITDA
$5,073.75 Mln
Net Profit
$927.03 Mln
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Acadia Healthcare (ACHC)
| 67.9 | 1.6 | 67.9 | -20.4 | -30.9 | -16.0 | -8.0 |
|
BSE Sensex
| -13.4 | -9.8 | -13.9 | -3.6 | 7.5 | 7.9 | 11.2 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Acadia Healthcare (ACHC)
| -64.2 | -48.7 | -5.5 | 35.6 | 20.8 | 51.3 | 29.2 |
|
S&P Small-Cap 600
| 4.0 | 7.0 | 13.9 | -17.4 | 25.3 | 9.6 | 20.9 |
|
BSE Sensex
| 9.1 | 8.1 | 18.7 | 4.4 | 22.0 | 15.8 | 14.4 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Acadia Healthcare (ACHC)
|
23.8 | 2,105.2 | 3,312.8 | -1,102.8 | -28.0 | -43.9 | -- | 1.1 |
| 13.7 | 3,186.8 | 3,125.0 | -262.7 | 0.9 | -313.2 | -- | 20.5 | |
| 377.9 | 5,278.0 | 2,530.0 | 265.2 | 14.2 | 25.3 | 20.1 | 5.3 | |
| 53.3 | 2,778.6 | 941.5 | 105.7 | 14.5 | 29.4 | 26.2 | 7.3 | |
| 96.5 | 9,812.1 | 5,935.2 | 566.2 | 18.1 | 25.1 | 17.6 | 3.9 | |
| 19.2 | 4,280.7 | 2,347.6 | 128.4 | 4.5 | 25.2 | 36.8 | 7.9 | |
| 27.3 | 4,285.8 | 5,649.5 | 207.6 | 7.0 | 15.2 | 21.3 | 3.3 | |
| 52.9 | 4,326.1 | 2,040.2 | -18.7 | 5.0 | -1.9 | -- | 4.0 | |
| 14.8 | 3,768.2 | 1,163.6 | 78.0 | 26.1 | 15.4 | 49.1 | 6.2 | |
| 194.9 | 11,646.4 | 5,057.8 | 344.0 | 9.2 | 16.9 | 34.4 | 5.2 |
Acadia Healthcare Company, Inc. provides behavioral healthcare services in the United States and Puerto Rico. The company owns and operates acute inpatient psychiatric facilities; specialty treatment facilities comprising residential recovery... facilities and eating disorder facilities; comprehensive treatment centers; and residential treatment centers, as well as facilities providing outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities. Acadia Healthcare Company, Inc. was founded in 2005 and is headquartered in Franklin, Tennessee. Address: 4020 Aspen Grove Drive, Franklin, TN, United States, 37067 Read more
CEO & Director
Mr. Christopher Howal Hunter
CEO & Director
Mr. Christopher Howal Hunter
Headquarters
Franklin, TN
Website
The share price of Acadia Healthcare Company Inc (ACHC) is $23.79 (NASDAQ) as of 02-Apr-2026 12:34 EDT. Acadia Healthcare Company Inc (ACHC) has given a return of -30.92% in the last 3 years.
Since, TTM earnings of Acadia Healthcare Company Inc (ACHC) is negative, P/E ratio is not available.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
-1.16
|
0.66
|
|
2024
|
14.27
|
1.19
|
|
2023
|
-329.72
|
2.57
|
|
2022
|
27.69
|
2.69
|
|
2021
|
28.99
|
2.14
|
The 52-week high and low of Acadia Healthcare Company Inc (ACHC) are Rs 30.17 and Rs 11.43 as of 02-Apr-2026.
Acadia Healthcare Company Inc (ACHC) has a market capitalisation of $ 2,105 Mln as on 31-Mar-2026. As per SEBI classification, it is a Small Cap company.
Before investing in Acadia Healthcare Company Inc (ACHC), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.